Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin

被引:64
作者
Kumamoto, Natsuko
Matsuzaki, Shinsuke
Inoue, Kiyoshi
Hattori, Tsuyoshi
Shimizu, Shoko
Hashimoto, Ryota
Yamatodani, Atsushi
Katayama, Taiichi
Tohyama, Masaya
机构
[1] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan
[2] 21st Century COE Program, Suita, Osaka 5650871, Japan
[3] Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Suita, Osaka 5650871, Japan
[4] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka 5650871, Japan
[5] Osaka Univ, Fac Med, Grad Sch Allied Hlth Sci, Dept Bioinformat, Suita, Osaka, Japan
[6] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo 1878502, Japan
[7] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4313192, Japan
关键词
schizophrenia; dysbindin; dopamine; SNAP25; PC12;
D O I
10.1016/j.bbrc.2006.04.163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extraordinal activation of nigrostriatal and mesolimbic dopaminergic systems (midbrain dopaminergic system) is thought to be one of the most important etiologies for schizophrenia, though the reason why unusual hyperactivation of the dopaminergic system occurs in the schizophrenic brain is quite obscure. Dysbindin, one of the most susceptible genes for schizophrenia, has been reported to be reduced in the schizophrenic brain. In situ hybridization analysis showed the mRNA expression of dysbindin in the mouse substantia nigra. Furthermore, suppression of dysbindin expression in PC12 cells resulted in an increase of the expression of SNAP25, which plays an important role in neurotransmitter release, and increased the release of dopamine. On the other hand, up-regulation of dysbindin expression in PC12 cells showed a tendency to decrease the expression of SNAP25. These data suggest that dysbindin might regulate the dopamine release of the dopaminergic system via modulation of the expression of SNAP25. © 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:904 / 909
页数:6
相关论文
共 42 条
[1]   CNS STIMULANTS AS TOOLS IN THE STUDY OF SCHIZOPHRENIA [J].
ANGRIST, B ;
VANKAMMEN, DP .
TRENDS IN NEUROSCIENCES, 1984, 7 (10) :388-390
[2]   THE BIOCHEMISTRY OF NEUROTRANSMITTER SECRETION [J].
BAJJALIEH, SM ;
SCHELLER, RH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (05) :1971-1974
[3]   Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain [J].
Benson, MA ;
Newey, SE ;
Martin-Rendon, E ;
Hawkes, R ;
Blake, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :24232-24241
[4]   Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression [J].
Bray, NJ ;
Preece, A ;
Williams, NM ;
Moskvina, V ;
Buckland, PR ;
Owen, MJ ;
O'Donovan, MC .
HUMAN MOLECULAR GENETICS, 2005, 14 (14) :1947-1954
[5]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[6]   Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia [J].
Fanous, AH ;
van den Oord, EJ ;
Riley, BP ;
Aggen, SH ;
Neale, MC ;
O'Neill, FA ;
Walsh, D ;
Kendler, KS .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (10) :1824-1832
[7]   Association of the DTNBP1 locus with schizophrenia in a US population [J].
Funke, B ;
Finn, CT ;
Plocik, AM ;
Lake, S ;
DeRosse, P ;
Kane, JM ;
Kucherlapati, R ;
Malhotra, AK .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (05) :891-898
[8]   The emerging role of glutamate in the pathophysiology and treatment of schizophrenia [J].
Goff, DC ;
Coyle, JT .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (09) :1367-1377
[9]  
GORNICK MC, 2005, J AUTISM DEV DISORD, V10, P1
[10]   RELEASE, STORAGE AND UPTAKE OF CATECHOLAMINES BY A CLONAL CELL LINE OF NERVE GROWTH-FACTOR (NGF) RESPONSIVE PHEOCHROMOCYTOMA CELLS [J].
GREENE, LA ;
REIN, G .
BRAIN RESEARCH, 1977, 129 (02) :247-263